Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index. | PLoS One | 2020 | 33095822 | PubTator, text mining | PubMed |
| Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as diffuse pulmonary infiltrates. | Clin Case Rep | 2020 | 33088554 | PubTator, text mining | PubMed |
| Identification and Expression Pattern of EZH2 in Pig Developing Fetuses. | Biomed Res Int | 2020 | 33083470 | PubTator, text mining | PubMed |
| Post-Transcriptional Expression Control in Platelet Biogenesis and Function. | Int J Mol Sci | 2020 | 33076269 | PubTator, text mining | PubMed |
| Structure and Emerging Functions of LRCH Proteins in Leukocyte Biology. | Front Cell Dev Biol | 2020 | 33072765 | PubTator, text mining | PubMed |
| Cellular Origins of the Lymphatic Endothelium: Implications for Cancer Lymphangiogenesis. | Front Physiol | 2020 | 33071831 | PubTator, text mining | PubMed |
| Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies. | Theranostics | 2020 | 33052226 | PubTator, text mining | PubMed |
| lncRNA involved in triptonide-induced cytotoxicity in mouse germ cells. | Reprod Toxicol | 2020 | 33045310 | PubTator, text mining | PubMed |
| RAC1 induces nuclear alterations through the LINC complex to enhance melanoma invasiveness. | Mol Biol Cell | 2020 | 33026942 | PubTator, text mining | PubMed |
| Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment. | Cancers (Basel) | 2020 | 33003469 | PubTator, text mining | PubMed |
| Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer. | Biomedicines | 2020 | 32993067 | PubTator, text mining | PubMed |
| Rho GTPases: Big Players in Breast Cancer Initiation, Metastasis and Therapeutic Responses. | Cells | 2020 | 32992837 | PubTator, text mining | PubMed |
| VAV1 mutations contribute to development of T-cell neoplasms in mice. | Blood | 2020 | 32992343 | PubTator, text mining | PubMed |
| Spotlight on the Granules (Grainyhead-Like Proteins) - From an Evolutionary Conserved Controller of Epithelial Trait to Pioneering the Chromatin Landscape. | Front Mol Biosci | 2020 | 32974388 | PubTator, text mining | PubMed |
| MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers. | Front Mol Neurosci | 2020 | 32973449 | PubTator, text mining | PubMed |
| VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma. | Nat Commun | 2020 | 32963234 | PubTator, text mining | PubMed |
| P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases. | Int J Mol Sci | 2020 | 32962005 | PubTator, text mining | PubMed |
Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW. | Phytomedicine | 2020 | 32949888 | PubTator, text mining | PubMed |
| A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis. | Int J Mol Med | 2020 | 32945366 | PubTator, text mining | PubMed |
| EZH2 reduction is an essential mechanoresponse for the maintenance of super-enhancer polarization against compressive stress in human periodontal ligament stem cells. | Cell Death Dis | 2020 | 32934212 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=47